{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:34:32Z","timestamp":1789796072891,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007419","name":"National Institute of Agrobiological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.12.015","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T15:26:36Z","timestamp":1671117996000},"page":"766-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity"],"prefix":"10.1016","volume":"41","author":[{"given":"Akitsu","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae","family":"Man Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kusakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.12.015_b0005","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJMra0804575","article-title":"Norovirus Gastroenteritis","volume":"361","author":"Glass","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.015_b0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/JCM.01535-14","article-title":"Advances in Laboratory Methods for Detection and Typing of Norovirus","volume":"53","author":"Vinj\u00e9","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.12.015_b0015","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/JCM.00499-08","article-title":"Analysis of Integrated Virological and Epidemiological Reports of Norovirus Outbreaks Collected within the Foodborne Viruses in Europe Network from 1 July 2001 to 30 June 2006","volume":"46","author":"Kroneman","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.12.015_b0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1086\/605127","article-title":"Norovirus Illness Is a Global Problem: Emergence and Spread of Norovirus GII.4 Variants, 2001\u20132007","volume":"200","author":"Siebenga","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.12.015_b0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/viro.1993.1345","article-title":"Sequence and Genomic Organization of Norwalk Virus","volume":"195","author":"Jiang","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2022.12.015_b0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0042-6822(03)00004-7","article-title":"Processing of Norwalk virus nonstructural proteins by a 3C-like cysteine proteinase","volume":"308","author":"Blakeney","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2022.12.015_b0035","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1128\/JVI.77.20.10957-10974.2003","article-title":"In Vitro Proteolytic Processing of the MD145 Norovirus ORF1 Nonstructural Polyprotein Yields Stable Precursors and Products Similar to Those Detected in Calicivirus-Infected Cells","volume":"77","author":"Belliot","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0040","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1128\/jvi.68.8.5117-5125.1994","article-title":"Three-dimensional structure of baculovirus-expressed Norwalk virus capsids","volume":"68","author":"Prasad","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2022.12.015_b0050","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/jvi.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12275-014-4323-6","article-title":"Function of VP2 protein in the stability of the secondary structure of virus-like particles of genogroup II norovirus at different pH levels: Function of VP2 protein in the stability of NoV VLPs","volume":"52","author":"Lin","year":"2014","journal-title":"J Microbiol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0060","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1128\/JVI.77.21.11603-11615.2003","article-title":"The 3\u2019 end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein","volume":"77","author":"Bertolotti-Ciarlet","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.015_b0065","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jcmgh.2018.11.001","article-title":"Human Norovirus Propagation in Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells","volume":"7","author":"Sato","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0070","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/jcm.31.8.2185-2191.1993","article-title":"Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations","volume":"31","author":"Green","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: Passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2022.12.015_b0080","doi-asserted-by":"crossref","unstructured":"Gomes AC, Mohsen M, Bachmann MF. Harnessing Nanoparticles for Immunomodulation and Vaccines. Vaccines 2017, Vol 5, Page 6 2017;5:6. doi: https:\/\/doi.org\/10.3390\/VACCINES5010006.","DOI":"10.3390\/vaccines5010006"},{"key":"10.1016\/j.vaccine.2022.12.015_b0085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fbioe.2019.00420","article-title":"Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development","volume":"7","author":"Tripathi","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114403","article-title":"Combined truncations at both N- and C-terminus of human papillomavirus type 58 L1 enhanced the yield of virus-like particles produced in a baculovirus system","volume":"301","author":"Wang","year":"2022","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2022.12.015_b0095","first-page":"26","article-title":"Biochemical characterization of the recombinant schistosome tegumental protein SmALDH_312 produced in E. coli and baculovirus expression vector system. Electron","volume":"54","author":"Harnischfeger","year":"2021","journal-title":"J Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.015_b0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jb\/mvq138","article-title":"Comparison of recombinant protein expression in a baculovirus system in insect cells (Sf9) and silkworm","volume":"149","author":"Usami","year":"2011","journal-title":"J Biochem"},{"issue":"7","key":"10.1016\/j.vaccine.2022.12.015_b0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1099\/jgv.0.001087","article-title":"Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae","volume":"99","author":"Masuda","year":"2018","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pep.2019.03.010","article-title":"Expression and purification of biologically active human granulocyte-macrophage colony stimulating factor (hGM-CSF) using silkworm-baculovirus expression vector system","volume":"159","author":"Kinoshita","year":"2019","journal-title":"Protein Expr Purif"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.015_b0115","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.aspen.2020.05.001","article-title":"Efficient production of recombinant T7 endonuclease I using silkworm-baculovirus expression vector system","volume":"23","author":"Kakino","year":"2020","journal-title":"J Asia Pac Entomol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0120","first-page":"161","article-title":"Construction of the BmNPV T3 Bacmid System and Its Application to the Functional Analysis of BmNPV he65","volume":"76","author":"Ono","year":"2007","journal-title":"J Insect Biotechnol Sericology"},{"key":"10.1016\/j.vaccine.2022.12.015_b0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BA20070098","article-title":"Improved expression of fusion protein using a cysteine- protease- and chitinase-deficient Bombyx mori (silkworm) multiple nucleopolyhedrovirus bacmid in silkworm larvae","volume":"49","author":"Park","year":"2008","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.vaccine.2022.12.015_b0130","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00705-004-0479-4","article-title":"Silk gland specific secretory expression of egfp gene in silkworm Bombyx mori with rAcMNPV system","volume":"150","author":"Guo","year":"2005","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.015_b0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10565-009-9133-y","article-title":"Genetic modification of a baculovirus vector for increased expression in insect cells","volume":"26","author":"Hitchman","year":"2010","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.015_b0140","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/JVI.02968-14","article-title":"Human Noroviruses\u2019 Fondness for Histo-Blood Group Antigens","volume":"89","author":"Singh","year":"2015","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.015_b0145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.06200-11","article-title":"Monoclonal Antibody-Based Antigenic Mapping of Norovirus GII.4-2002","volume":"86","author":"Lindesmith","year":"2012","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.12.015_b0150","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/v11050392","article-title":"In Depth Breadth Analyses of Human Blockade Responses to Norovirus and Response to Vaccination","volume":"11","author":"Haynes","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2022.12.015_b0155","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.micinf.2014.02.010","article-title":"Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays","volume":"16","author":"Uusi-Kerttula","year":"2014","journal-title":"Microbes Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.015_b0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.aspen.2016.03.014","article-title":"High-level expression and purification of biologically active human IL-2 using silkworm-baculovirus expression vector system","volume":"19","author":"Hino","year":"2016","journal-title":"J Asia Pac Entomol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.015_b0165","doi-asserted-by":"crossref","first-page":"e1001807","DOI":"10.1371\/journal.pmed.1001807","article-title":"Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial","volume":"12","author":"Lindesmith","year":"2015","journal-title":"PLOS Med"},{"issue":"41","key":"10.1016\/j.vaccine.2022.12.015_b0170","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1016\/j.vaccine.2020.07.069","article-title":"Efficacy of an intramuscular bivalent norovirus GI.1\/GII.4 virus-like particle vaccine candidate in healthy US adults","volume":"38","author":"Sherwood","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.015_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2011.05.009","article-title":"Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus","volume":"179","author":"Koho","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2022.12.015_b0180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pep.2018.06.011","article-title":"High-level expression and enrichment of norovirus virus-like particles in plants using modified geminiviral vectors","volume":"151","author":"Diamos","year":"2018","journal-title":"Protein Expr Purif"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.015_b0185","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00705-019-04192-2","article-title":"The coordinating role of the human norovirus minor capsid protein VP2 is essential to functional change and nuclear localization of the major capsid protein VP1","volume":"164","author":"Liu","year":"2019","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0190","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/JVI.03508-12","article-title":"Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain","volume":"87","author":"Vongpunsawad","year":"2013","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.015_b0195","doi-asserted-by":"crossref","first-page":"e79575","DOI":"10.1371\/journal.pone.0079575","article-title":"Canine Parvovirus VP2 Protein Expressed in Silkworm Pupae Self-Assembles into Virus-Like Particles with High Immunogenicity","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2022.12.015_b0200","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1016\/j.vaccine.2017.08.079","article-title":"Production of highly immunogenic virus-like particles of bovine papillomavirus type 6 in silkworm pupae","volume":"35","author":"Watanabe","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.015_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803647","article-title":"Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants","volume":"12","author":"Masuda","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0210","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00705-010-0768-z","article-title":"A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles","volume":"155","author":"Huhti","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12560-015-9198-0","article-title":"Zeta Potential and Aggregation of Virus-Like Particle of Human Norovirus and Feline Calicivirus Under Different Physicochemical Conditions","volume":"7","author":"Samandoulgou","year":"2015","journal-title":"Food Environ Virol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12934-014-0134-z","article-title":"Secreted production of assembled Norovirus virus-like particles from Pichia pastoris","volume":"13","author":"Tom\u00e9-Amat","year":"2014","journal-title":"Microb Cell Fact"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.015_b0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jviromet.2012.01.003","article-title":"Purification of norovirus-like particles (VLPs) by ion exchange chromatography","volume":"181","author":"Koho","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2022.12.015_b0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2020.10.005","article-title":"Structural heterogeneity of a human norovirus vaccine candidate","volume":"553","author":"Devant","year":"2021","journal-title":"Virology"},{"issue":"16","key":"10.1016\/j.vaccine.2022.12.015_b0235","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1128\/JVI.01192-14","article-title":"Particle Conformation Regulates Antibody Access to a Conserved GII.4 Norovirus Blockade Epitope","volume":"88","author":"Lindesmith","year":"2014","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.015_b0240","first-page":"597","article-title":"Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled","volume":"217","author":"Leroux-Roels","year":"2018","journal-title":"Double-Blind Clinical Trial. J Infect Dis"},{"issue":"36","key":"10.1016\/j.vaccine.2022.12.015_b0245","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1016\/j.vaccine.2020.06.011","article-title":"A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose","volume":"38","author":"Treanor","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.015_b0250","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.vaccine.2005.07.071","article-title":"Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calves","volume":"24","author":"Han","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.015_b0255","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-021-00971-5","article-title":"Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice","volume":"52","author":"Masuda","year":"2021","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2022.12.015_b0260","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2567.2011.03516.x","article-title":"A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles","volume":"135","author":"Tamminen","year":"2012","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.vaccine.2022.12.015_b0265","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/CVI.00196-15","article-title":"Serological correlates of protection against a GII.4 norovirus","volume":"22","author":"Atmar","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.12.015_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.922867","article-title":"Screening immune adjuvants for an inactivated vaccine against Erysipelothrix rhusiopathiae","volume":"9","author":"Guan","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2022.12.015_b0275","first-page":"99","article-title":"Structure of Freund\u2019s complete and incomplete adjuvants. Relation of adjuvanticity to structure","volume":"27","author":"Dvorak","year":"1974","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.015_b0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/v11020091","article-title":"Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant","volume":"11","author":"Tamminen","year":"2019","journal-title":"Viruses"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:23:12Z","timestamp":1759404192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22015298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22015298"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}